​

Syndax Pharmaceuticals (SNDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Syndax Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$172.35M

Latest Revenue (Q)

$45.87M

Main Segment (Y)

Net Product Revenues

Syndax Pharmaceuticals Revenue by Period

Syndax Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$172.35M627.84%
2024-12-31$23.68M100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$139.71M9109.56%
2020-12-31$1.52M-
2019-12-31$1.52M-
2018-12-31$1.52M-28.04%
2017-12-31$2.11M72.79%
2016-12-31$1.22M94.58%
2015-12-31$627.00K100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Syndax Pharmaceuticals generated $172.35M in revenue during NA 2025, up 627.84% compared to the previous quarter, and up 11361.37% compared to the same period a year ago.

Syndax Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30$45.87M20.85%
2025-06-30$37.96M89.39%
2025-03-31$20.04M160.96%
2024-12-31$7.68M-38.56%
2024-09-30$12.50M257.14%
2024-06-30$3.50M100.00%
2024-03-31--100.00%
2023-12-31$536.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$126.58M922.84%
2021-09-30$12.38M3165.17%
2021-06-30$379.00K-
2021-03-31$379.00K-0.26%
2020-12-31$380.00K0.26%
2020-09-30$379.00K-
2020-06-30$379.00K-
2020-03-31$379.00K-0.26%
2019-12-31$380.00K0.26%
2019-09-30$379.00K-
2019-06-30$379.00K-
2019-03-31$379.00K-0.26%
2018-12-31$380.00K0.26%
2018-09-30$379.00K-
2018-06-30$379.00K-
2018-03-31$379.00K-68.23%
2017-12-31$1.19M291.15%
2017-09-30$305.00K-
2017-06-30$305.00K-
2017-03-31$305.00K-
2016-12-31$305.00K-
2016-09-30$305.00K-
2016-06-30$305.00K-
2016-03-31$305.00K-
2015-12-31$305.00K-
2015-09-30$305.00K1694.12%
2015-06-30$17.00K100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Syndax Pharmaceuticals generated $45.87M in revenue during Q3 2025, up 20.85% compared to the previous quarter, and up 1310.60% compared to the same period a year ago.

Syndax Pharmaceuticals Revenue Breakdown

Syndax Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Collaboration revenue$42.37M-
Net Product Revenues$124.84M$7.68M
Milestone Revenue$5.14M$16.00M

Syndax Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Net Product Revenues (72.44%), Collaboration revenue (24.58%), and Milestone Revenue (2.98%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25
Collaboration revenue$19.14M$13.86M$9.36M
Product-$32.01M$28.60M

Syndax Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Collaboration revenue (100.00%).

Syndax Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SNDXSyndax Pharmaceuticals$172.35M$45.87M
NKTRNektar Therapeutics$98.43M$11.79M
IMTXImmatics$54.00M$30.45M
CVACCureVac$52.70M$12.37M
RLAYRelay Therapeutics$15.36M-
ZBIOZenas BioPharma$5.00M-
INBXInhibrx Biosciences$200.00K-
ATAIAtai Beckley N.V-$749.00K
SANASana Bio--
AMLXAmylyx Pharmaceuticals--
ORICORIC Pharmaceuticals--

SNDX Revenue FAQ

What is Syndax Pharmaceuticals’s yearly revenue?

Syndax Pharmaceuticals's yearly revenue for 2025 was $172.35M, representing an increase of 627.84% compared to 2024. The company's yearly revenue for 2024 was $23.68M, representing an increase of 100.00% compared to 2023. SNDX's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Syndax Pharmaceuticals’s quarterly revenue?

Syndax Pharmaceuticals's quarterly revenue for Q3 2025 was $45.87M, a 20.85% increase from the previous quarter (Q2 2025), and a 266.97% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $37.96M, a 89.39% increase from the previous quarter (Q1 2025), and a 984.51% increase year-over-year (Q2 2024). SNDX's quarterly revenue for Q1 2025 was $20.04M, a 160.96% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Syndax Pharmaceuticals’s revenue growth rate?

Syndax Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 23.36%.

What are Syndax Pharmaceuticals’s revenue streams?

Syndax Pharmaceuticals's revenue streams in c 25 are Collaboration revenue, Net Product Revenues, and Milestone Revenue. Collaboration revenue generated $42.37M in revenue, accounting 24.58% of the company's total revenue Net Product Revenues generated $124.84M in revenue, accounting 72.44% of the company's total revenue, up 1525.57% year-over-year. Milestone Revenue generated $5.14M in revenue, accounting 2.98% of the company's total revenue, down -67.87% year-over-year.

What is Syndax Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Syndax Pharmaceuticals was Net Product Revenues. This segment made a revenue of $124.84M, representing 72.44% of the company's total revenue.